Kingston University

Country: United Kingdom

Kingston University is a well-established UK university, founded in 1899, with a strong and growing international reputation. It has a diverse community of over 20,000 students from 140 countries and is recognised as the UK’s leading university for “Future Skills,” preparing students to thrive in a changing world.

The University is known for its commitment to excellent teaching, innovation, and improving students’ life chances, as well as supporting staff development and making a positive impact on industry, policy, and society. It focuses on creating a sustainable future—socially, economically, and environmentally.

Its high standards in teaching and student support have been recognised with Gold ratings in all three categories of the UK’s Teaching Excellence Framework (TEF), placing Kingston among only 26 higher education institutions in the country to achieve this distinction.

The KU team belong to the school of Pharmacy and have significant experience in designing and conducting in depth needs assessment and evaluation strategies for digital interventions using a mix of quantitative and qualitative research methods.

Role in the project: 

Kingston University (KU) leads key work packages WP4 and WP5, focusing on building local implementation capacity and coordinating MULTIPULM activities. KU is responsible for analysing the current landscape of multimorbidity management, designing the implementation framework, engaging and coordinating stakeholders, and delivering user training and awareness programs. The University also oversees ethical approvals, conducts impact evaluations, and performs health technology assessments. In addition, KU manages several key deliverables, ensuring the project progresses effectively and achieves its objectives.

People Involved: 

Prof. Shereen Nabhani-Gebara - Principal Investigator (PI)

Prof. Reem Kayyali - Co-Principal Investigator (Co-PI)

Dr. Anishta Mehdi Mohammad - Research Associate